ArticleTranslational cancer research2025
Race, gender, and safety: exposing biases in minimally invasive lung cancer surgery research.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Video- and robotic-assisted thoracic surgery are proven safe alternatives to open thoracotomy. But smaller-scale studies examining outcomes between minimally invasive surgery (MIS) and open techniques may fail to capture patterns in health, gender, and race on a national scale. The aim of this study was to identify large-scale trends in the outcomes of MIS in a national database. Methods: We evaluated adverse events following MIS and open lung resection in the Surveillance, Epidemiology, and End Results (SEER) Medicare database from 1992-2015. Results: A total of 746,441 patients were diagnosed with lung cancer. MIS patients undergoing limited resection (n=5,185) were more likely to be older (74.7 Conclusions: There are multiple differences between MIS and open surgery, but it is unclear if any confer a clinical benefit. Patients undergoing MIS tend to be healthier with earlier-stage disease, suggesting biases in patient selection. The data suggests that lung cancer should be considered a women's health issue and raises the concern that Black Americans do not have equal access to screening and treatment. While these results support the continued use of MIS, they should not substitute good surgical judgment when open surgery is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.